Authors: Press, AG Hauptmann, IA Hauptmann, L Fuchs, B Fuchs, M Ewe, K Ramadori, G

Citation: Ag. Press et al., Gastrointestinal pH profiles in patients with inflammatory bowel disease (vol 12, pg 673, 1998), ALIM PHARM, 15(9), 2001, pp. 1513-1513

Authors: Meuwissen, SGM Ewe, K Gassull, MA Geboes, K Jewell, D Pallone, F Rachmilewitz, D Rask-Madsen, J Riddell, BH Sandborn, BJ Schmuck, ML

Citation: Sgm. Meuwissen et al., IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine,cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases, EUR J GASTR, 12(1), 2000, pp. 13-18

Authors: Ewe, K Bottger, T Buhr, HJ Ecker, KW Otto, HF

Citation: K. Ewe et al., Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial, EUR J GASTR, 11(3), 1999, pp. 277-282

Authors: Ewe, K Schwartz, S Petersen, S Press, AG

Citation: K. Ewe et al., Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease, DIG DIS SCI, 44(7), 1999, pp. 1434-1439

Authors: Lochs, H Adler, G Beglinger, C Duchmann, R Emmrich, J Ewe, K Gangl, A Gasche, C Hahn, E Hoffmann, P Kaskas, B Malchow, H Pohl, C Raedler, A Renner, E Scholmerich, J Schreiber, S Stange, E Tilg, H Vogelsang, H Weigert, N Zeitz, M

Citation: H. Lochs et al., Anti-TNF antibody in Crohn's disease - status of information, comments andrecommendations of an international working group, Z GASTROENT, 37(6), 1999, pp. 509-512